Clinical Microbiologists as Decision-Support Specialists: Clinicians' Views on Microbiology Consultation, Stewardship, and the Future Role of the Specialty

IF 2.2 4区 医学 Q4 IMMUNOLOGY
Apmis Pub Date : 2026-07-29 DOI:10.1111/apm.70243
Einar Nilsen
{"title":"Clinical Microbiologists as Decision-Support Specialists: Clinicians' Views on Microbiology Consultation, Stewardship, and the Future Role of the Specialty","authors":"Einar Nilsen","doi":"10.1111/apm.70243","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The clinical value of microbiological diagnostics depends on whether results are translated into bedside decisions. There are differing opinions and traditions around what role the physician microbiologist should have in this translation from laboratory results to treatment. We performed a cross-sectional questionnaire study among hospital clinicians in Møre and Romsdal Health Trust, Norway, to explore perceptions of microbiology-based decision support and the future role of physician clinical microbiologists. A total of 251 clinicians responded. Of these, 85.7% treated patients with suspected or confirmed infection more often than monthly. Among this key clinical subgroup, 90.7% considered microbiology decision support to be in the top two of five categories of usefulness; only 0.8% found it not useful. 94.9% found the advice professionally relevant, 95.8% found it easy to translate into action, 98.1% reported usually following recommendations, 88.8% reported that the support contributed to better antibiotic use, 87.0% to faster or safer clinical decisions, and 97.7% were positive toward an active clinical advisory role by physician clinical microbiologists. The findings support a clinically integrated model where clinical microbiologists contribute not only as laboratory specialists, but as decision-support partners in infection management.</p>\n </div>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"134 8","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Apmis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apm.70243","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The clinical value of microbiological diagnostics depends on whether results are translated into bedside decisions. There are differing opinions and traditions around what role the physician microbiologist should have in this translation from laboratory results to treatment. We performed a cross-sectional questionnaire study among hospital clinicians in Møre and Romsdal Health Trust, Norway, to explore perceptions of microbiology-based decision support and the future role of physician clinical microbiologists. A total of 251 clinicians responded. Of these, 85.7% treated patients with suspected or confirmed infection more often than monthly. Among this key clinical subgroup, 90.7% considered microbiology decision support to be in the top two of five categories of usefulness; only 0.8% found it not useful. 94.9% found the advice professionally relevant, 95.8% found it easy to translate into action, 98.1% reported usually following recommendations, 88.8% reported that the support contributed to better antibiotic use, 87.0% to faster or safer clinical decisions, and 97.7% were positive toward an active clinical advisory role by physician clinical microbiologists. The findings support a clinically integrated model where clinical microbiologists contribute not only as laboratory specialists, but as decision-support partners in infection management.

作为决策支持专家的临床微生物学家:临床医生对微生物学咨询、管理和该专业未来角色的看法。
微生物诊断的临床价值取决于结果是否转化为床边决策。在从实验室结果到治疗的翻译中,医生微生物学家应该扮演什么样的角色,存在不同的观点和传统。我们在挪威Møre和Romsdal Health Trust的医院临床医生中进行了一项横断面问卷调查,以探讨基于微生物学的决策支持和临床微生物学家医师未来的作用。共有251名临床医生做出了回应。其中,85.7%对疑似或确诊感染患者的治疗频率超过每月一次。在这一关键的临床亚组中,90.7%的人认为微生物学决策支持在五类有用性中排名前两位;只有0.8%的人认为它没有用。94.9%的人认为建议与专业相关,95.8%的人认为建议易于转化为行动,98.1%的人通常遵循建议,88.8%的人认为支持有助于更好地使用抗生素,87.0%的人认为支持有助于更快或更安全的临床决策,97.7%的人认为临床微生物学家医师积极发挥临床咨询作用。研究结果支持临床整合模型,其中临床微生物学家不仅作为实验室专家,而且作为感染管理的决策支持伙伴。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Apmis
Apmis 医学-病理学
CiteScore
5.20
自引率
0.00%
发文量
91
审稿时长
2 months
期刊介绍: APMIS, formerly Acta Pathologica, Microbiologica et Immunologica Scandinavica, has been published since 1924 by the Scandinavian Societies for Medical Microbiology and Pathology as a non-profit-making scientific journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书